John Kerr posted in flu • infectious disease • influenza • pandemic • public health • tamiflu on April 11th, 2014.
A new analysis of withheld studies has questioned the usefulness of antiviral drug Tamiflu in the event of an influenza pandemic. The review, undertaken by the independent Cochrane Collaboration, examined data from pharmaceutical company trials involving over 24,000 patients. The authors of the report concluded that, while neuramidase inhibitors — a class of drug which […]
Continue reading “Tamiflu review spurs debate over stockpiling”